Al-Maidan Clinic for Oral Health Services Company K.S.C.P. (KWSE:MIDAN)
Kuwait · Delayed Price · Currency is KWD · Price in KWF 1.000
+0.030 (3.09%)
At close: Aug 26, 2026
KWSE:MIDAN Income Statement
Financials in millions KWD. Fiscal year is April - March.
Millions KWD. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 63.39 | 63.17 | 72 | 75.75 | 72.6 | 70.82 | |
Revenue Growth | -6.68% | -12.26% | -4.96% | 4.35% | 2.52% | 16.21% |
Cost of Revenue | 47.82 | 48.13 | 53.16 | 53.64 | 47.69 | 47.01 |
Gross Profit | 15.57 | 15.04 | 18.84 | 22.12 | 24.91 | 23.81 |
Selling, General & Admin | 4.66 | 5.55 | 8.83 | 9.09 | 8.47 | 8.88 |
Other Operating Expenses | 0.38 | 0.33 | 0.36 | 0.39 | 0.44 | 0.38 |
Operating Expenses | 7.81 | 8.29 | 12.72 | 12.32 | 12.02 | 10.61 |
Operating Income | 7.76 | 6.75 | 6.12 | 9.8 | 12.89 | 13.2 |
Interest Expense | -0.19 | -0.24 | -0.11 | -0.17 | -0.1 | -0.1 |
Interest & Investment Income | 2.05 | 2.16 | 2.03 | 2.16 | 0.18 | 0.09 |
Earnings From Equity Investments | 0.89 | 0.72 | -0.28 | -0.36 | -1.07 | -0.05 |
Other Non Operating Income (Expenses) | 0.84 | 0.72 | 1.92 | 0.72 | 1.39 | 0.93 |
EBT Excluding Unusual Items | 11.35 | 10.12 | 9.68 | 12.15 | 13.29 | 14.07 |
Gain (Loss) on Sale of Investments | -0.43 | -0.34 | 1.27 | 0.15 | -0.67 | -1.37 |
Gain (Loss) on Sale of Assets | 0.12 | 0.12 | -0.01 | - | - | - |
Asset Writedown | 0.01 | 0.01 | -0.03 | - | 0.02 | -2.16 |
Other Unusual Items | -0.25 | -0.25 | -1.49 | -0.34 | -0.31 | -0.13 |
Pretax Income | 10.8 | 9.65 | 9.41 | 11.97 | 12.34 | 10.41 |
Income Tax Expense | 0.14 | 0.13 | 0.14 | 0.16 | 0.18 | 0.15 |
Earnings From Continuing Operations | 10.66 | 9.53 | 9.27 | 11.81 | 12.16 | 10.25 |
Minority Interest in Earnings | -0.01 | -0.01 | -0 | 0.01 | 0.02 | 0.03 |
Net Income | 10.65 | 9.52 | 9.27 | 11.82 | 12.18 | 10.28 |
Net Income to Common | 10.65 | 9.52 | 9.27 | 11.82 | 12.18 | 10.28 |
Net Income Growth | 27.01% | 2.70% | -21.57% | -3.00% | 18.49% | 31.70% |
Shares Outstanding (Basic) | 203 | 203 | 203 | 206 | 224 | 225 |
Shares Outstanding (Diluted) | 203 | 203 | 203 | 206 | 224 | 225 |
Shares Change | - | - | -1.88% | -7.81% | -0.50% | - |
EPS (Basic) | 0.05 | 0.05 | 0.05 | 0.06 | 0.05 | 0.05 |
EPS (Diluted) | 0.05 | 0.05 | 0.05 | 0.06 | 0.05 | 0.05 |
EPS Growth | 27.01% | 2.70% | -20.07% | 5.22% | 19.09% | 31.70% |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | 6.84 | 5.7 | 7.01 | 12.57 | 13.62 | 19.94 |
Free Cash Flow Per Share | 0.03 | 0.03 | 0.04 | 0.06 | 0.06 | 0.09 |
Dividend Per Share | 0.020 | 0.020 | 0.015 | 0.010 | 0.006 | - |
Dividend Growth | 33.33% | 33.33% | 50.00% | 78.57% | -49.55% | - |
Gross Margin | 24.57% | 23.81% | 26.17% | 29.20% | 34.32% | 33.62% |
Operating Margin | 12.25% | 10.69% | 8.50% | 12.94% | 17.76% | 18.64% |
Profit Margin | 16.79% | 15.07% | 12.87% | 15.60% | 16.78% | 14.52% |
Free Cash Flow Margin | 10.80% | 9.02% | 9.73% | 16.60% | 18.75% | 28.16% |
EBITDA | 10.14 | 9.12 | 8.39 | 11.82 | 14.63 | 14.84 |
EBITDA Margin | 16.00% | 14.44% | 11.65% | 15.61% | 20.16% | 20.96% |
D&A For EBITDA | 2.38 | 2.36 | 2.26 | 2.02 | 1.74 | 1.64 |
EBIT | 7.76 | 6.75 | 6.12 | 9.8 | 12.89 | 13.2 |
EBIT Margin | 12.25% | 10.69% | 8.50% | 12.94% | 17.76% | 18.64% |
Effective Tax Rate | 1.31% | 1.31% | 1.53% | 1.31% | 1.45% | 1.46% |